.
-/mice have growth retardation. a, Schematic diagram of the strategy used to generate Grasp55 -/mice (Gorasp2 tm1(KOMP)Vlcg , strain; KOMP Repository, Oakland, CA, USA). The genotyping primer regions are marked with black and yellow arrows. b, PCR genotyping of genomic DNA samples from mice generated by heterozygote (+/-) crosses. c, d, Photographs of wild-type (Grasp55 +/+ ) and Grasp55 -/mice at embryonic day 18.5 (c), postnatal day 7 (d) . Source data are provided as a Source Data file. Supplementary Fig. 2 | Brown adipose tissues are reduced in Grasp55 -/mice. a, b, Photograph (a) and weight (b) of brown adipose tissue (BAT) of Grasp55 +/+ and Grasp55 -/mice at 4 weeks of age (n = 6). c, d, Histologic examination of BAT (H&E staining). Representative light microscopic tissue images are presented in (c). Quantitative analyses of the H&E images, that inversely correlate with fat contents of BAT by counting the number of adipocyte nuclei in a light microscopic field (450  340 μm), are depicted in (d, n = 10) . Data are shown as mean ± SEM. Scale bars: 50 μm. *p < 0.05, **p < 0.01. All p values were calculated by unpaired two-tailed Student's t tests. Source data are provided as a Source Data file. Supplementary Fig. 4 | GRASP55 deficiency reduces dietary lipid absorption but does not affect amino acid absorption in mice. a, An oral fat tolerance test (OFTT) was performed in Grasp55 +/+ and Grasp55 -/mice without tyloxapol treatment. Mice received oral gavage with olive oil (10 μl/g of body weight) after 16 h fasting. Triglyceride (TG) concentrations were determined in blood plasma (n = 6). b-d, Intestinal absorption of amino acids was measured in Grasp55 +/+ and Grasp55 -/mice at the age of 12 weeks using 14 Cradiolabeled glycine (b), L-proline (c), and L-tryptophan (d) as described in Methods (each n = 4). Data are shown as mean ± SEM. n.s.: not significant, *p < 0.05, **p < 0.01. P values were calculated by unpaired (a) or paired (b, c and d) two-tailed Student's t tests. Source data are provided as a Source Data file.
Supplementary Fig. 5 | Measurement of cholesterol in plasma fractions and intestines. a, b,
Cholesterol content was determined in each blood plasma fraction after fast performance liquid chromatography of plasma lipids from Grasp55 +/+ and Grasp55 -/mice. Blood samples were taken 2 h after oral gavage with olive oil. The cholesterol content in each fraction is presented in (a). The area under curve (AUC) of plasma lipoprotein fractions was measured using ImageJ software and is summarized in (b). The data represent three independent experiments using pooled blood plasma from three to four mice. GRASP55 deletion reduces cholesterol contents in chylomicron (CM)/VLDL fractions. c, d, Intestinal cholesterol (c) and cholesteryl ester (d) levels were measured in the jejunum in 12-week-old Grasp55 +/+ and Grasp55 -/mice fasted for 16 h (HFD -), followed by high-fat diet feeding for 4 h (HFD +) (n = 6). Data are shown as mean ± SEM. n.s.: not significant, *p < 0.05. P values were calculated by paired (b) or unpaired (c and d) two-tailed Student's t tests. Source data are provided as a Source Data file. Representative immunoblots are shown in (a). Densitometric analyses are shown in (b) (n = 4 for each). β-actin was monitored as a cytosolic protein loading control. c, Immunohistochemistry was performed using jejunums of Grasp55 +/+ and Grasp55 -/mice. GRASP55 deletion did not alter the Golgi localization of GM130, Golgin97, GRASP65, and Golgin45 (green, apical side of perinuclear regions in the jejunal epithelia). Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (blue). Three independent experiments showed similar results. Unprocessed blots are presented in Supplementary   Fig. 22 . Data are shown as mean ± SEM. n.s.: not significant. All p values were calculated by paired two-tailed Student's t tests. Scale bars: 20 μm. Source data are provided as a Source Data file. Supplementary Fig. 8 | See next page for caption. Supplementary Fig. 8 | Subcellular localizations of ATGL and MGL are altered by GRASP55 deficiency in mouse intestines. Membrane fractionation analysis was performed using intestinal epithelial cells of Grasp55 +/+ and Grasp55 -/mice fed normal diet. Membrane fractions of jejunal epithelial cells were separated by density gradient ultracentrifugation using an OptiPrep gradient, followed by immunoblotting with the indicated antibodies. Organelle markers used are as follows: Giantin (for the Golgi), ERGIC53 (for the ER-Golgi intermediate compartment), Calreticulin (a, for the ER), and BiP (b, for the ER). The Golgi localizations of ATGL (a) and MGL (b) were markedly reduced by GRASP55 deficiency in mouse intestinal cells (red and blue boxes). Three independent experiments were performed and showed similar results. AADAC, arylacetamide deacetylase; ADPN, Adiponutrin (PNPLA3, patatin-like phospholipase domain-containing protein 3); APOA1, apolipoprotein A1; APOA4, apolipoprotein A4; APOB48, apolipoprotein B48; ARF1, ADP-ribosylation factor 1; ARFRP1, ADP-ribosylation factor-related protein 1; ATGL, adipose triglyceride lipase; CES1, carboxylesterase 1; CES3, carboxylesterase 3; CIDEB, cell death-inducing DFFA-like effector B; CGI58, comparative gene identification-58; DGAT2, diglyceride acyltransferase 2; GBF1, Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1; HSL, hormone-sensitive lipase; LAL, lysosomal acid lipase; LIPC, hepatic triglyceride lipase; MGAT2, monoacylglycerol acyltransferase-2; MGL, monoglyceride lipase; MTP, microsomal triglyceride transfer protein. Unprocessed blots can be found in Supplementary Fig. 22 . Source data are provided as a Source Data file. Fig. 5b . The levels of pHSL, HSL, and MTP were not altered by GRASP55 depletion. e, f, The protein expression of MGL was analyzed by immunoblotting. Representative immunoblots are shown in (e) and densitometric analysis of multiple experiments is shown in (f, n = 4). The level of βactin was monitored as a cytosolic protein loading control. g, h, Quantitative PCR analysis of ATGL (g, n = 5) and MGL (h, n = 5) mRNAs. GRASP55 depletion reduces cytosolic MGL levels without affecting its mRNA levels. Unprocessed blots can be found in Supplementary Fig. 22 . HSL, hormonesensitive lipase; MGL, monoglyceride lipase; MTP, microsomal triglyceride transfer protein. Data are shown as mean ± SEM. n.s.: not significant, *p < 0.05. All p values were calculated by unpaired twotailed Student's t tests. Source data are provided as a Source Data file. Supplementary Fig. 12 | GRASP55 depletion induces failure in the LD-targeting of ATGL in HeLa Cells. a, The expression levels of GRASP55 proteins were examined in HeLa cells, in which GRASP55 was depleted (shGRASP55, shG55, open arrowhead) and/or exogenously supplemented (GRASP55-Myc, G55-Myc, filled arrowhead). Aldolase A was used as a cytosolic protein loading control. b, Presence of ATGL in LD surface was examined by co-staining with anti-ATGL antibodies and BODIPY 493/503 (an LD marker) in HeLa cells following treatment with 400 μM oleic acid for 4 h. Arrows indicate the location of ATGL targeted to the peripheral regions of LDs. Three independent experiments showed similar results. Unprocessed blots are presented in Supplementary Fig. 22 . Scale bars: 10 μm. Source data are provided as a Source Data file. Supplementary Fig. 13 | GRASP55 does not localize on LDs. Localization of GRASP55 was examined by co-staining with anti-GRASP55 antibodies and BODIPY 493/503 (an LD marker) in Caco-2 cells following treatment with 400 μM oleic acid for 16 h. Three independent experiments showed similar results. Scale bars: 10 μm. Supplementary Fig. 14 | Decreased ATGL levels in LDs by ER-to-Golgi blockade are not reversed by proteasome inhibition. Immunoblot analyses of ATGL levels in LDs and cell lysates of Caco-2 cells were performed in the absence or presence of the proteasomal inhibitor MG132 (0.5 μM, 16 h). The ER-to-Golgi trafficking was blocked by dominant-inhibitory forms of SAR1 (SAR1-T39N) and ARF1 (ARF1-T31N). For the induction of ATGL protein expression, cells were treated with 400 μM oleic acid for 16 h. Representative immunoblots of LDs and cytosols are shown in (a). In panels (b-d), the results of multiple experiments of RAB18, ADRP, and ATGL, respectively, are summarized (n = 3 each). Aldolase A was used as a cytosolic protein loading control. MG132 does not rescue the decreased RAB18, ADRP, or ATGL levels induced by SAR1-T39N and ARF1-T31N. Unprocessed blots can be found in Supplementary Fig. 22 . Data are shown as mean ± SEM. *p < 0.05. **p < 0.01. All p values were calculated by ANOVA followed by Tukey's multiple comparison tests. Source data are provided as a Source Data file. Supplementary Fig. 15 | GRASP55 does not alter the protein stability of GBF1 and ARF1 in Caco-2 cells. Immunoblot analysis of GBF1 and ARF1 levels were performed in control and GRASP55-depleted Caco-2 cells, stably transfected with shRNA against GRASP55 (shGRASP55). Some cells were incubated with the proteasomal inhibitor MG132 (0.5 μM, 16 h). Representative immunoblots are shown in (a). Densitometric analyses of GBF1 and ARF1 are shown in (b) and (c), respectively (n = 3 for each). GBF1 and ARF1 levels were not altered by GRASP55 depletion or by treatment with MG132 (compare with the results obtained for ATGL, shown in Supplementary Fig. 13 ). Unprocessed blots are presented in Supplementary Fig. 22 . Data are shown as mean ± SEM. n.s.: not significant. All p values were calculated by unpaired two-tailed Student's t tests. Source data are provided as a Source Data file. Supplementary Fig. 16 | Autophagic flux is not altered by Grasp55 deletion in the mouse jejunum. To analyze the effects of GRASP55 deficiency on autophagy, conversion of microtubule-associated protein light chain 3 (LC3) into its phosphatidylethanolamineconjugated form (LC3-II) as a parameter of autophagic flux was examined. The jejunum samples were taken from ad libitum-fed mice. Some samples were taken 2 h after olive oil feeding (10 μl/g body weight). Under both conditions, deletion of Grasp55 did not affect LC3-II conversion. Representative immunoblots (a) and the results of densitometric analyses (b) (n = 4) are shown. Unprocessed blots are presented in Supplementary Fig. 22 . Data are shown as mean ± SEM. n.s.: not significant. All p values were calculated by unpaired two-tailed Student's t tests. Source data are provided as a Source Data file. Supplementary Fig. 17 | GRASP55 deficiency decreases the cellular levels of ATGL and triglyceride contents in mouse hepatocytes. a-d, Immunoblot analysis of ATGL, MTP, and HSL in the mouse liver. Liver tissues were prepared from 12-week-old Grasp55 +/+ and Grasp55 -/mice fed on the normal diet. A representative immunoblot is shown in (a), and the results of multiple experiments (n = 4) are summarized in (b-d) . The amount of β-actin was monitored as a cytosolic protein loading control. e, f, Morphological analysis of mouse livers fasted for 16 h or after olive oil bolus (olive oil, 10 μl/g of body weight) by H&E staining and electro-microscopy (EM). White arrows indicate the cytosolic LDs. Note that LD size is reduced in Grasp55 -/mice. Quantitative analyses of LD diameters are summarized in (f, Grasp55 +/+ , n = 296 from five mice; Grasp55 -/-, n = 150 from five mice). GRASP55 deficiency reduced the LD size from 1.23 ± 0.04 m to 0.73 ± 0.03 m (p < 0.01). g, The amount of triglyceride (TG) per g liver was measured (n = 6). Unprocessed blots can be found in Supplementary Fig. 22 . Data are shown as mean ± SEM. Scale bars: 50 μm (H&E) and 5 μm (EM). n.s.: not significant, **p < 0.01. P values were calculated by paired (b, c and d) or unpaired (g) two-tailed Student's t tests. Source data are provided as a Source Data file. Fig. 22 | Unprocessed images of blots in Figures 1-9 
